Immunological Characteristics of Patients With PID and IBD
Immunological Characteristics of Patients With Primary Immunodeficiencies and Inflammatory Bowel Diseases
Sponsor: Sheba Medical Center
Listed as NCT03148028, this observational or N/A phase trial focuses on Inflammatory Bowel Diseases and Primary Immune Deficiency Disorder and remains ongoing. Sponsored by Sheba Medical Center, it has been updated 12 times since 2017, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
12 versions recorded-
Sep 2025 — Present [monthly]
Unknown
-
Sep 2024 — Sep 2025 [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Dec 2021 — Jul 2024 [monthly]
Unknown Status
-
Feb 2021 — Dec 2021 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
▶ Show 7 earlier versions
-
Jan 2021 — Feb 2021 [monthly]
Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Recruiting
-
Jun 2018 — Nov 2020 [monthly]
Recruiting
-
May 2018 — Jun 2018 [monthly]
Recruiting
-
Apr 2018 — May 2018 [monthly]
Recruiting
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Recruiting NA
-
Jun 2017 — Aug 2017 [monthly]
Recruiting NA
First recorded
May 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Sheba Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .